Company Overview

Update
Founded:
2011
Headquarters:
New York, NY
Funding:
$23M
Categories:
Software

River Vision Development develops a protein therapy for the treatment of Graves’ orbitopathy.

Description

Update

River Vision Development Corp. develops RV001, a protein therapy for the treatment of Graves’ Orbitopathy (GO). The company was founded in 2011 and is based in New York, New York.

Funding Rounds (2) - $23M

Update

Investors (3)

Update

Offices/Locations (1)

Update
  • Office

    One Rockefeller Plaza

    New York, NY 10020

    USA